Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zfp384
|
ENSMUSG00000038346.12 | zinc finger protein 384 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_125008634_125008823 | Zfp384 | 417 | 0.659250 | 0.64 | 2.8e-08 | Click! |
chr6_125009489_125010173 | Zfp384 | 26 | 0.940375 | 0.49 | 6.4e-05 | Click! |
chr6_125009047_125009485 | Zfp384 | 10 | 0.941794 | 0.47 | 1.7e-04 | Click! |
chr6_125011131_125011282 | Zfp384 | 814 | 0.379217 | 0.21 | 1.1e-01 | Click! |
chr6_125004441_125004651 | Zfp384 | 4599 | 0.088663 | -0.18 | 1.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_16103301_16104345 | 5.46 |
Rpl7 |
ribosomal protein L7 |
404 |
0.8 |
chr2_52038470_52039720 | 4.98 |
Tnfaip6 |
tumor necrosis factor alpha induced protein 6 |
1086 |
0.54 |
chr12_108605770_108606876 | 4.76 |
Evl |
Ena-vasodilator stimulated phosphoprotein |
557 |
0.74 |
chr9_41584760_41585051 | 4.67 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2864 |
0.14 |
chr13_28949369_28949858 | 4.18 |
Sox4 |
SRY (sex determining region Y)-box 4 |
4100 |
0.25 |
chrX_96712746_96713886 | 4.12 |
Gpr165 |
G protein-coupled receptor 165 |
125 |
0.98 |
chr1_111862798_111863699 | 4.09 |
Dsel |
dermatan sulfate epimerase-like |
1520 |
0.41 |
chr3_83767702_83768200 | 4.02 |
Sfrp2 |
secreted frizzled-related protein 2 |
1098 |
0.49 |
chr9_35423074_35423780 | 3.92 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
161 |
0.95 |
chr6_147261988_147262635 | 3.87 |
Pthlh |
parathyroid hormone-like peptide |
1856 |
0.31 |
chr3_127407787_127409013 | 3.68 |
Ank2 |
ankyrin 2, brain |
554 |
0.71 |
chr8_12947702_12949640 | 3.67 |
Mcf2l |
mcf.2 transforming sequence-like |
718 |
0.37 |
chrX_88114828_88115362 | 3.64 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
550 |
0.84 |
chr13_28949179_28949330 | 3.51 |
Sox4 |
SRY (sex determining region Y)-box 4 |
4459 |
0.24 |
chr4_13206879_13207436 | 3.50 |
Gm26250 |
predicted gene, 26250 |
59893 |
0.15 |
chr16_81201314_81201888 | 3.46 |
Ncam2 |
neural cell adhesion molecule 2 |
844 |
0.72 |
chr4_102760289_102761654 | 3.45 |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
446 |
0.87 |
chr3_13472022_13472431 | 3.40 |
Gm2464 |
predicted gene 2464 |
397 |
0.59 |
chr5_111421306_111422790 | 3.40 |
Gm43119 |
predicted gene 43119 |
1541 |
0.35 |
chr7_84677795_84678092 | 3.38 |
Zfand6 |
zinc finger, AN1-type domain 6 |
1408 |
0.4 |
chr2_6883618_6884699 | 3.35 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr10_64089736_64090806 | 3.31 |
Lrrtm3 |
leucine rich repeat transmembrane neuronal 3 |
3 |
0.99 |
chr8_90956080_90956960 | 3.30 |
Chd9 |
chromodomain helicase DNA binding protein 9 |
1085 |
0.49 |
chr13_23438314_23438627 | 3.28 |
C230035I16Rik |
RIKEN cDNA C230035I16 gene |
7448 |
0.08 |
chr7_30558948_30559627 | 3.27 |
Lin37 |
lin-37 homolog (C. elegans) |
352 |
0.6 |
chr7_128688434_128689045 | 3.24 |
Gm43580 |
predicted gene 43580 |
204 |
0.53 |
chr17_17404544_17405433 | 3.23 |
Lix1 |
limb and CNS expressed 1 |
2316 |
0.23 |
chr11_34315006_34315399 | 3.20 |
Insyn2b |
inhibitory synaptic factor family member 2B |
380 |
0.85 |
chr10_59969941_59970891 | 3.19 |
Ddit4 |
DNA-damage-inducible transcript 4 |
18582 |
0.15 |
chr19_38224310_38224709 | 3.14 |
Fra10ac1 |
FRA10AC1 homolog (human) |
353 |
0.87 |
chr11_61453075_61454398 | 3.12 |
Rnf112 |
ring finger protein 112 |
183 |
0.92 |
chr4_103620947_103621657 | 3.07 |
Dab1 |
disabled 1 |
1637 |
0.37 |
chr1_77512287_77513134 | 3.05 |
Epha4 |
Eph receptor A4 |
2369 |
0.26 |
chr4_72195085_72196381 | 3.04 |
Tle1 |
transducin-like enhancer of split 1 |
3359 |
0.26 |
chr3_145118136_145118409 | 3.04 |
Odf2l |
outer dense fiber of sperm tails 2-like |
316 |
0.9 |
chr18_69595622_69596635 | 3.03 |
Tcf4 |
transcription factor 4 |
1946 |
0.44 |
chr3_63905126_63905789 | 3.02 |
Gm34379 |
predicted gene, 34379 |
28 |
0.97 |
chr16_90388047_90389721 | 3.01 |
Hunk |
hormonally upregulated Neu-associated kinase |
2871 |
0.22 |
chr6_136171003_136171483 | 3.01 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
646 |
0.69 |
chr18_72350573_72351222 | 3.01 |
Dcc |
deleted in colorectal carcinoma |
120 |
0.98 |
chr2_32430451_32431664 | 2.99 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
47 |
0.95 |
chr14_55054119_55054818 | 2.96 |
Gm20687 |
predicted gene 20687 |
477 |
0.41 |
chr11_58302619_58303189 | 2.95 |
Zfp692 |
zinc finger protein 692 |
4165 |
0.12 |
chr8_32292517_32293013 | 2.94 |
Nrg1 |
neuregulin 1 |
148 |
0.98 |
chr14_54652781_54653677 | 2.89 |
Acin1 |
apoptotic chromatin condensation inducer 1 |
10 |
0.93 |
chr19_38263947_38265363 | 2.89 |
Lgi1 |
leucine-rich repeat LGI family, member 1 |
5 |
0.97 |
chrX_43428799_43429673 | 2.88 |
Tenm1 |
teneurin transmembrane protein 1 |
110 |
0.97 |
chr16_77418973_77419718 | 2.87 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
2475 |
0.17 |
chr5_131535782_131536209 | 2.86 |
Auts2 |
autism susceptibility candidate 2 |
1598 |
0.38 |
chr3_108410436_108412210 | 2.85 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
4229 |
0.11 |
chr7_78989959_78991095 | 2.85 |
Gm26633 |
predicted gene, 26633 |
62796 |
0.08 |
chr9_25253505_25253730 | 2.84 |
Septin7 |
septin 7 |
951 |
0.54 |
chr1_75168983_75169681 | 2.84 |
Zfand2b |
zinc finger, AN1 type domain 2B |
404 |
0.63 |
chrX_136115088_136116396 | 2.83 |
5730412P04Rik |
RIKEN cDNA 5730412P04 gene |
11139 |
0.12 |
chr12_49378198_49378768 | 2.80 |
Gm34304 |
predicted gene, 34304 |
3402 |
0.17 |
chr19_46057688_46057839 | 2.79 |
Pprc1 |
peroxisome proliferative activated receptor, gamma, coactivator-related 1 |
504 |
0.7 |
chr1_194622071_194623282 | 2.78 |
Plxna2 |
plexin A2 |
2851 |
0.26 |
chr12_27336880_27337279 | 2.77 |
Sox11 |
SRY (sex determining region Y)-box 11 |
5495 |
0.31 |
chrX_74296668_74296928 | 2.76 |
Atp6ap1 |
ATPase, H+ transporting, lysosomal accessory protein 1 |
299 |
0.72 |
chr10_69705909_69707430 | 2.76 |
Ank3 |
ankyrin 3, epithelial |
191 |
0.97 |
chr6_13835523_13837039 | 2.76 |
Gpr85 |
G protein-coupled receptor 85 |
960 |
0.59 |
chr3_83768357_83769273 | 2.72 |
Sfrp2 |
secreted frizzled-related protein 2 |
1962 |
0.31 |
chr6_4745558_4745709 | 2.72 |
Sgce |
sarcoglycan, epsilon |
1430 |
0.31 |
chr12_27338037_27338443 | 2.69 |
Sox11 |
SRY (sex determining region Y)-box 11 |
4334 |
0.33 |
chr18_13968574_13969239 | 2.68 |
Zfp521 |
zinc finger protein 521 |
2814 |
0.38 |
chr7_67848611_67849816 | 2.68 |
Gm39027 |
predicted gene, 39027 |
419 |
0.8 |
chr11_110399154_110400265 | 2.67 |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
450 |
0.88 |
chr1_131523488_131524457 | 2.67 |
Srgap2 |
SLIT-ROBO Rho GTPase activating protein 2 |
3375 |
0.18 |
chr12_95691954_95693678 | 2.66 |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
590 |
0.73 |
chr6_24526872_24527545 | 2.65 |
Ndufa5 |
NADH:ubiquinone oxidoreductase subunit A5 |
318 |
0.78 |
chr11_87110117_87110562 | 2.65 |
Ska2 |
spindle and kinetochore associated complex subunit 2 |
1088 |
0.28 |
chr4_82507895_82509049 | 2.64 |
Gm11266 |
predicted gene 11266 |
456 |
0.82 |
chr12_49389021_49389211 | 2.63 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
536 |
0.68 |
chr6_136171767_136172200 | 2.61 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
94 |
0.95 |
chr5_103209022_103210413 | 2.61 |
Mapk10 |
mitogen-activated protein kinase 10 |
705 |
0.75 |
chr19_59463596_59464359 | 2.61 |
Emx2 |
empty spiracles homeobox 2 |
1175 |
0.44 |
chrX_95163813_95164963 | 2.60 |
Arhgef9 |
CDC42 guanine nucleotide exchange factor (GEF) 9 |
1437 |
0.48 |
chr6_15185454_15186399 | 2.58 |
Foxp2 |
forkhead box P2 |
363 |
0.93 |
chr14_96517868_96518996 | 2.56 |
Klhl1 |
kelch-like 1 |
670 |
0.78 |
chr11_54902577_54902810 | 2.56 |
Gpx3 |
glutathione peroxidase 3 |
79 |
0.96 |
chr6_124916509_124917019 | 2.55 |
A230083G16Rik |
RIKEN cDNA A230083G16 gene |
99 |
0.9 |
chr16_72215544_72215934 | 2.54 |
8030451O07Rik |
RIKEN cDNA 8030451O07 gene |
18563 |
0.27 |
chr8_96455054_96456367 | 2.54 |
Gm32122 |
predicted gene, 32122 |
51848 |
0.14 |
chr7_3390544_3391386 | 2.54 |
Cacng8 |
calcium channel, voltage-dependent, gamma subunit 8 |
282 |
0.73 |
chr2_165882235_165884653 | 2.53 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
766 |
0.54 |
chr9_10903843_10905236 | 2.53 |
Cntn5 |
contactin 5 |
90 |
0.65 |
chr11_42181593_42182279 | 2.51 |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1 |
168 |
0.97 |
chr3_19896760_19896990 | 2.50 |
4632415L05Rik |
RIKEN cDNA 4632415L05 gene |
1893 |
0.32 |
chr17_17828911_17829692 | 2.49 |
Mir99b |
microRNA 99b |
887 |
0.24 |
chr1_14307063_14308005 | 2.49 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
2302 |
0.39 |
chr6_86403336_86403797 | 2.48 |
Tia1 |
cytotoxic granule-associated RNA binding protein 1 |
653 |
0.51 |
chr2_90579116_90579417 | 2.48 |
Ptprj |
protein tyrosine phosphatase, receptor type, J |
1381 |
0.48 |
chr15_89476279_89476848 | 2.48 |
C230037L18Rik |
RIKEN cDNA C230037L18 gene |
311 |
0.56 |
chr10_90576163_90577493 | 2.47 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
13 |
0.99 |
chr1_168429421_168430005 | 2.46 |
Pbx1 |
pre B cell leukemia homeobox 1 |
1791 |
0.44 |
chr2_125625334_125625568 | 2.46 |
Cep152 |
centrosomal protein 152 |
338 |
0.9 |
chr1_173389412_173390669 | 2.46 |
Cadm3 |
cell adhesion molecule 3 |
22345 |
0.14 |
chr8_61227862_61229170 | 2.45 |
Sh3rf1 |
SH3 domain containing ring finger 1 |
4272 |
0.23 |
chr2_45107349_45107914 | 2.45 |
Zeb2 |
zinc finger E-box binding homeobox 2 |
2445 |
0.28 |
chr7_73558867_73559450 | 2.45 |
1810026B05Rik |
RIKEN cDNA 1810026B05 gene |
763 |
0.51 |
chr11_106217587_106217842 | 2.44 |
Ddx42 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 42 |
788 |
0.38 |
chr12_9577276_9578110 | 2.44 |
Osr1 |
odd-skipped related transcription factor 1 |
3252 |
0.23 |
chr16_96192359_96192600 | 2.42 |
Lca5l |
Leber congenital amaurosis 5-like |
208 |
0.92 |
chr7_29784973_29785497 | 2.42 |
Zfp30 |
zinc finger protein 30 |
1151 |
0.29 |
chr1_97931687_97931838 | 2.42 |
Gm3531 |
predicted pseudogene 3531 |
17627 |
0.19 |
chr9_44360875_44361574 | 2.42 |
Vps11 |
VPS11, CORVET/HOPS core subunit |
410 |
0.57 |
chr7_24236694_24237224 | 2.41 |
Zfp109 |
zinc finger protein 109 |
266 |
0.82 |
chr1_126828978_126829702 | 2.41 |
Nckap5 |
NCK-associated protein 5 |
1141 |
0.62 |
chr6_86404872_86405499 | 2.41 |
Tia1 |
cytotoxic granule-associated RNA binding protein 1 |
712 |
0.48 |
chr9_41587766_41588181 | 2.41 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
204 |
0.89 |
chr1_42700192_42700666 | 2.40 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
4661 |
0.15 |
chr7_97842700_97844158 | 2.39 |
Pak1 |
p21 (RAC1) activated kinase 1 |
494 |
0.83 |
chr16_39109478_39110008 | 2.39 |
Gm36742 |
predicted gene, 36742 |
79163 |
0.1 |
chr14_79486576_79487850 | 2.38 |
Wbp4 |
WW domain binding protein 4 |
5693 |
0.16 |
chr17_17402413_17403374 | 2.38 |
Lix1 |
limb and CNS expressed 1 |
221 |
0.91 |
chr1_136231257_136232167 | 2.37 |
Inava |
innate immunity activator |
1402 |
0.26 |
chr17_51461105_51461697 | 2.37 |
Gm46574 |
predicted gene, 46574 |
23320 |
0.19 |
chr8_115705039_115705190 | 2.37 |
Gm15655 |
predicted gene 15655 |
36 |
0.98 |
chr10_73096427_73097649 | 2.37 |
Pcdh15 |
protocadherin 15 |
2304 |
0.33 |
chr2_97468266_97469202 | 2.37 |
Lrrc4c |
leucine rich repeat containing 4C |
645 |
0.83 |
chrX_7187545_7188725 | 2.37 |
Clcn5 |
chloride channel, voltage-sensitive 5 |
538 |
0.71 |
chr15_103238802_103239455 | 2.35 |
Cbx5 |
chromobox 5 |
688 |
0.47 |
chr10_18408068_18409081 | 2.34 |
Nhsl1 |
NHS-like 1 |
899 |
0.67 |
chr3_114030507_114031514 | 2.33 |
Col11a1 |
collagen, type XI, alpha 1 |
376 |
0.93 |
chrX_75577567_75578361 | 2.33 |
Rab39b |
RAB39B, member RAS oncogene family |
267 |
0.81 |
chr18_65582281_65582868 | 2.33 |
Zfp532 |
zinc finger protein 532 |
39 |
0.95 |
chr17_90087597_90088717 | 2.32 |
Nrxn1 |
neurexin I |
17 |
0.99 |
chr17_74489119_74489379 | 2.31 |
Yipf4 |
Yip1 domain family, member 4 |
244 |
0.9 |
chr1_86358173_86358456 | 2.31 |
Ncl |
nucleolin |
655 |
0.39 |
chr11_100711444_100712070 | 2.31 |
Kat2a |
K(lysine) acetyltransferase 2A |
416 |
0.67 |
chr8_94266327_94267391 | 2.30 |
Nup93 |
nucleoporin 93 |
12 |
0.96 |
chr1_171280206_171281120 | 2.30 |
Ppox |
protoporphyrinogen oxidase |
97 |
0.9 |
chr6_86523951_86524435 | 2.30 |
1600020E01Rik |
RIKEN cDNA 1600020E01 gene |
2054 |
0.15 |
chr1_143640264_143641520 | 2.29 |
B3galt2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
228 |
0.59 |
chrX_37082184_37082433 | 2.29 |
Snora69 |
small nucleolar RNA, H/ACA box 69 |
734 |
0.49 |
chr8_124947096_124947456 | 2.29 |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
2048 |
0.25 |
chr8_94869714_94871671 | 2.28 |
Dok4 |
docking protein 4 |
512 |
0.65 |
chr4_97582473_97584218 | 2.28 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
1251 |
0.53 |
chr13_23516807_23517151 | 2.27 |
n-TStga1 |
nuclear encoded tRNA serine 1 (anticodon TGA) |
1163 |
0.19 |
chr6_144202688_144204608 | 2.26 |
Sox5 |
SRY (sex determining region Y)-box 5 |
409 |
0.92 |
chr3_88685086_88685562 | 2.26 |
Khdc4 |
KH domain containing 4, pre-mRNA splicing factor |
479 |
0.55 |
chr11_70018020_70018411 | 2.25 |
Dlg4 |
discs large MAGUK scaffold protein 4 |
226 |
0.8 |
chr7_144238658_144240098 | 2.25 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
653 |
0.8 |
chr15_78915623_78916717 | 2.25 |
Pdxp |
pyridoxal (pyridoxine, vitamin B6) phosphatase |
2251 |
0.12 |
chr13_83987947_83988519 | 2.24 |
Gm4241 |
predicted gene 4241 |
242 |
0.93 |
chr10_6979289_6980565 | 2.23 |
Ipcef1 |
interaction protein for cytohesin exchange factors 1 |
216 |
0.96 |
chr1_135583494_135584229 | 2.23 |
Gm4793 |
predicted gene 4793 |
912 |
0.48 |
chr4_82501450_82502014 | 2.23 |
Nfib |
nuclear factor I/B |
2416 |
0.3 |
chr4_96552598_96553907 | 2.23 |
Cyp2j6 |
cytochrome P450, family 2, subfamily j, polypeptide 6 |
409 |
0.87 |
chr8_110266991_110267758 | 2.23 |
Gm26832 |
predicted gene, 26832 |
88 |
0.83 |
chr13_48968858_48969048 | 2.21 |
Fam120a |
family with sequence similarity 120, member A |
936 |
0.65 |
chr3_51275843_51276078 | 2.21 |
4930577N17Rik |
RIKEN cDNA 4930577N17 gene |
799 |
0.44 |
chr1_17727029_17728148 | 2.21 |
Gm16070 |
predicted gene 16070 |
58 |
0.89 |
chr18_54989606_54990178 | 2.21 |
Zfp608 |
zinc finger protein 608 |
274 |
0.6 |
chr18_40257309_40257704 | 2.20 |
Kctd16 |
potassium channel tetramerisation domain containing 16 |
483 |
0.67 |
chr11_94045498_94046076 | 2.20 |
Spag9 |
sperm associated antigen 9 |
1422 |
0.4 |
chr16_22263818_22263981 | 2.20 |
Tra2b |
transformer 2 beta |
2001 |
0.22 |
chr17_51534362_51535054 | 2.19 |
Gm31143 |
predicted gene, 31143 |
150 |
0.97 |
chr2_167063295_167064001 | 2.19 |
Gm25878 |
predicted gene, 25878 |
175 |
0.64 |
chr7_80269712_80270440 | 2.18 |
Vps33b |
vacuolar protein sorting 33B |
336 |
0.76 |
chr5_23616072_23616572 | 2.18 |
Srpk2 |
serine/arginine-rich protein specific kinase 2 |
212 |
0.93 |
chr1_11413602_11414901 | 2.18 |
A830018L16Rik |
RIKEN cDNA A830018L16 gene |
18 |
0.98 |
chr11_40755370_40755698 | 2.18 |
Ccng1 |
cyclin G1 |
223 |
0.93 |
chr12_67219520_67219941 | 2.18 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
1312 |
0.58 |
chr6_18511684_18512389 | 2.18 |
Cttnbp2 |
cortactin binding protein 2 |
1055 |
0.59 |
chr9_107706739_107707764 | 2.17 |
Sema3f |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
1695 |
0.2 |
chr6_114282516_114283979 | 2.17 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
457 |
0.87 |
chr19_60144553_60145749 | 2.16 |
E330013P04Rik |
RIKEN cDNA E330013P04 gene |
447 |
0.84 |
chr4_9668043_9668363 | 2.15 |
Asph |
aspartate-beta-hydroxylase |
883 |
0.45 |
chr18_65583033_65584701 | 2.15 |
Zfp532 |
zinc finger protein 532 |
70 |
0.95 |
chr13_28415894_28416204 | 2.14 |
Gm40841 |
predicted gene, 40841 |
3814 |
0.3 |
chr8_54954519_54955779 | 2.14 |
Gpm6a |
glycoprotein m6a |
306 |
0.88 |
chr4_62966572_62967137 | 2.13 |
Zfp618 |
zinc finger protein 618 |
1280 |
0.42 |
chr12_33147776_33148198 | 2.13 |
Atxn7l1 |
ataxin 7-like 1 |
182 |
0.72 |
chr3_19406311_19407021 | 2.13 |
Pde7a |
phosphodiesterase 7A |
95344 |
0.07 |
chr7_6730584_6731228 | 2.13 |
Usp29 |
ubiquitin specific peptidase 29 |
39 |
0.74 |
chr4_109979229_109979380 | 2.13 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
1251 |
0.41 |
chr8_84765171_84766430 | 2.12 |
Nfix |
nuclear factor I/X |
7596 |
0.11 |
chr9_61510253_61510471 | 2.11 |
Gm34424 |
predicted gene, 34424 |
639 |
0.76 |
chr14_124677116_124677780 | 2.11 |
Fgf14 |
fibroblast growth factor 14 |
321 |
0.92 |
chr10_128175501_128176488 | 2.11 |
Rbms2 |
RNA binding motif, single stranded interacting protein 2 |
485 |
0.62 |
chr2_119046311_119046521 | 2.10 |
Knl1 |
kinetochore scaffold 1 |
703 |
0.56 |
chr18_54988564_54988904 | 2.10 |
Zfp608 |
zinc finger protein 608 |
1432 |
0.35 |
chr5_88583963_88584847 | 2.10 |
Rufy3 |
RUN and FYVE domain containing 3 |
611 |
0.7 |
chr14_58072231_58072956 | 2.10 |
Fgf9 |
fibroblast growth factor 9 |
93 |
0.97 |
chr5_34550299_34550725 | 2.10 |
Sh3bp2 |
SH3-domain binding protein 2 |
824 |
0.45 |
chr9_86743069_86744445 | 2.10 |
Prss35 |
protease, serine 35 |
108 |
0.95 |
chr2_21205049_21205596 | 2.10 |
Enkur |
enkurin, TRPC channel interacting protein |
30 |
0.87 |
chr14_93888035_93888426 | 2.09 |
Pcdh9 |
protocadherin 9 |
502 |
0.87 |
chr9_35426329_35426747 | 2.09 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
2950 |
0.22 |
chr12_27339427_27339967 | 2.08 |
Sox11 |
SRY (sex determining region Y)-box 11 |
2877 |
0.38 |
chr1_37299560_37299784 | 2.08 |
1700074A21Rik |
RIKEN cDNA 1700074A21 gene |
25 |
0.71 |
chr7_62462160_62463169 | 2.08 |
Peg12 |
paternally expressed 12 |
1846 |
0.31 |
chr1_42699114_42699733 | 2.08 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
3655 |
0.16 |
chr8_107824151_107824995 | 2.07 |
Gm23646 |
predicted gene, 23646 |
16384 |
0.19 |
chr11_46727761_46728251 | 2.07 |
Gm12174 |
predicted gene 12174 |
188 |
0.93 |
chr1_40085123_40085879 | 2.07 |
Gm16894 |
predicted gene, 16894 |
350 |
0.57 |
chr14_39471112_39471496 | 2.07 |
Nrg3 |
neuregulin 3 |
1362 |
0.61 |
chr5_41342073_41342328 | 2.06 |
Gm4754 |
predicted gene 4754 |
77 |
0.98 |
chr18_69596863_69597074 | 2.06 |
Tcf4 |
transcription factor 4 |
2568 |
0.37 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 10.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.9 | 2.9 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
2.1 | 6.3 | GO:0021856 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
2.1 | 2.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
2.0 | 6.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.9 | 11.4 | GO:0060174 | limb bud formation(GO:0060174) |
1.9 | 3.7 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.8 | 1.8 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.7 | 8.7 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
1.7 | 5.0 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.6 | 4.9 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.6 | 4.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.5 | 4.6 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.5 | 3.0 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.4 | 7.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
1.4 | 4.3 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
1.4 | 5.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.4 | 4.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.3 | 14.8 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
1.3 | 10.7 | GO:0031223 | auditory behavior(GO:0031223) |
1.3 | 4.0 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
1.3 | 2.6 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.3 | 2.6 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
1.2 | 5.0 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.2 | 3.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.2 | 3.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.2 | 4.7 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.1 | 3.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.1 | 8.0 | GO:0097264 | self proteolysis(GO:0097264) |
1.1 | 3.4 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.1 | 3.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.1 | 9.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.1 | 5.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.1 | 3.3 | GO:0060437 | lung growth(GO:0060437) |
1.1 | 3.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.1 | 6.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.1 | 4.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.1 | 3.2 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.0 | 3.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
1.0 | 3.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.0 | 5.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.0 | 3.1 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
1.0 | 6.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.0 | 3.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.0 | 3.1 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
1.0 | 3.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.0 | 3.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.0 | 1.0 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
1.0 | 3.0 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.0 | 2.9 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.0 | 2.9 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
1.0 | 3.9 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.0 | 6.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.0 | 3.9 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
1.0 | 2.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.9 | 3.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.9 | 1.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.9 | 2.8 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.9 | 1.9 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.9 | 2.8 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.9 | 2.8 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.9 | 1.8 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.9 | 2.8 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.9 | 2.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.9 | 2.7 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.9 | 3.7 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.9 | 4.6 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.9 | 6.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.9 | 6.3 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.9 | 1.8 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.9 | 4.5 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.9 | 2.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.9 | 8.0 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.9 | 0.9 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.9 | 2.6 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.9 | 3.5 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.9 | 3.5 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.9 | 1.7 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.9 | 3.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.8 | 2.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.8 | 2.5 | GO:0030242 | pexophagy(GO:0030242) |
0.8 | 3.4 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.8 | 0.8 | GO:0070384 | Harderian gland development(GO:0070384) |
0.8 | 1.7 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.8 | 3.4 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.8 | 1.7 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.8 | 7.5 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.8 | 2.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.8 | 0.8 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.8 | 8.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.8 | 2.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.8 | 1.6 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.8 | 1.6 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.8 | 2.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.8 | 3.1 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.8 | 2.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.8 | 0.8 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.8 | 6.1 | GO:0060074 | synapse maturation(GO:0060074) |
0.8 | 2.3 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.8 | 2.3 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.7 | 3.0 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.7 | 7.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.7 | 2.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.7 | 2.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.7 | 2.2 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.7 | 6.6 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.7 | 0.7 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.7 | 0.7 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.7 | 2.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.7 | 2.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.7 | 5.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.7 | 2.9 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.7 | 0.7 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.7 | 0.7 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.7 | 4.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.7 | 2.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.7 | 4.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.7 | 2.8 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.7 | 2.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.7 | 2.8 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.7 | 5.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.7 | 2.8 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.7 | 4.1 | GO:0015074 | DNA integration(GO:0015074) |
0.7 | 3.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.7 | 2.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.7 | 2.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.7 | 2.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.7 | 2.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.7 | 2.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.7 | 0.7 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.7 | 7.4 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.7 | 2.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.7 | 2.0 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.7 | 1.3 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.7 | 2.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.7 | 2.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.7 | 2.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.7 | 1.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.7 | 1.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.7 | 0.7 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.7 | 2.6 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.7 | 2.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.7 | 1.3 | GO:1901629 | regulation of presynaptic membrane organization(GO:1901629) |
0.7 | 2.6 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.7 | 9.8 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.7 | 2.6 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.6 | 3.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.6 | 1.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.6 | 3.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 1.3 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.6 | 0.6 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.6 | 0.6 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.6 | 3.8 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.6 | 2.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.6 | 1.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.6 | 0.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.6 | 0.6 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.6 | 1.9 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.6 | 0.6 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.6 | 3.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 3.8 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.6 | 2.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.6 | 13.2 | GO:0001964 | startle response(GO:0001964) |
0.6 | 0.6 | GO:0086011 | membrane repolarization during action potential(GO:0086011) regulation of membrane repolarization during action potential(GO:0098903) |
0.6 | 9.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.6 | 3.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.6 | 0.6 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.6 | 1.9 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.6 | 2.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.6 | 1.9 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.6 | 6.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.6 | 2.5 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.6 | 1.8 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.6 | 1.8 | GO:1904395 | positive regulation of postsynaptic membrane organization(GO:1901628) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.6 | 6.7 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.6 | 9.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.6 | 1.2 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.6 | 1.8 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.6 | 0.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.6 | 1.8 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.6 | 1.8 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.6 | 2.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.6 | 1.8 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.6 | 3.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.6 | 3.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.6 | 3.6 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.6 | 1.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.6 | 3.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.6 | 1.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.6 | 0.6 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.6 | 2.9 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.6 | 4.7 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.6 | 1.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.6 | 2.9 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.6 | 0.6 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.6 | 3.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.6 | 2.3 | GO:1903748 | negative regulation of protein targeting to mitochondrion(GO:1903215) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.6 | 2.9 | GO:0045006 | DNA deamination(GO:0045006) |
0.6 | 0.6 | GO:0040031 | snRNA modification(GO:0040031) |
0.6 | 0.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.6 | 1.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.6 | 4.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.6 | 2.3 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.6 | 3.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.6 | 1.7 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.6 | 2.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.6 | 2.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.6 | 1.7 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.6 | 1.7 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.6 | 1.7 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.6 | 6.8 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.6 | 1.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.6 | 0.6 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.6 | 0.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.6 | 5.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.6 | 1.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.6 | 0.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.6 | 3.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.6 | 1.7 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.6 | 0.6 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) negative regulation of ATP biosynthetic process(GO:2001170) |
0.6 | 1.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.6 | 1.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.6 | 1.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.5 | 1.1 | GO:0021586 | pons maturation(GO:0021586) |
0.5 | 1.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.5 | 2.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.5 | 4.9 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.5 | 1.6 | GO:0048254 | snoRNA localization(GO:0048254) |
0.5 | 2.2 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) |
0.5 | 3.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.5 | 1.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.5 | 2.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.5 | 1.6 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.5 | 6.9 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.5 | 2.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.5 | 11.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.5 | 2.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.5 | 2.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.5 | 1.6 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.5 | 0.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.5 | 1.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.5 | 6.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.5 | 1.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.5 | 1.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.5 | 4.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.5 | 2.6 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.5 | 3.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.5 | 0.5 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.5 | 5.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.5 | 1.0 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.5 | 1.5 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.5 | 1.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.5 | 4.1 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.5 | 1.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.5 | 1.5 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.5 | 8.7 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.5 | 1.0 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.5 | 3.6 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.5 | 1.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 0.5 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.5 | 1.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.5 | 5.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.5 | 4.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.5 | 1.0 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.5 | 0.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.5 | 4.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.5 | 1.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.5 | 4.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.5 | 3.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.5 | 4.0 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.5 | 4.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.5 | 2.5 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.5 | 4.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.5 | 1.5 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 3.0 | GO:0006983 | ER overload response(GO:0006983) |
0.5 | 2.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.5 | 1.5 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.5 | 2.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.5 | 1.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.5 | 4.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.5 | 7.4 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.5 | 0.5 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.5 | 3.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.5 | 2.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.5 | 2.4 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.5 | 1.5 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.5 | 0.5 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.5 | 1.9 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.5 | 4.9 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.5 | 1.0 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.5 | 1.9 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.5 | 1.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.5 | 1.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.5 | 5.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.5 | 7.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.5 | 2.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.5 | 1.0 | GO:0039531 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039531) |
0.5 | 2.4 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.5 | 1.4 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.5 | 1.9 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.5 | 3.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.5 | 0.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.5 | 0.5 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.5 | 1.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.5 | 0.5 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.5 | 0.9 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.5 | 1.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 2.8 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.5 | 5.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.5 | 2.8 | GO:0070417 | cellular response to cold(GO:0070417) |
0.5 | 1.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.5 | 2.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.5 | 1.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.5 | 1.9 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.5 | 1.9 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.5 | 0.9 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.5 | 2.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.5 | 1.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.5 | 2.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.5 | 1.9 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.5 | 1.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.5 | 0.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.5 | 0.5 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.5 | 5.0 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.5 | 2.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.5 | 0.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.5 | 0.5 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.5 | 3.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.5 | 2.3 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.5 | 2.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.5 | 5.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.5 | 0.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.5 | 1.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.5 | 1.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.5 | 0.9 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.5 | 0.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.4 | 0.4 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.4 | 0.4 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.4 | 1.3 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.4 | 0.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.4 | 5.8 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.4 | 0.9 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
0.4 | 0.4 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.4 | 3.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.4 | 1.3 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) |
0.4 | 0.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 0.4 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.4 | 3.5 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.4 | 8.8 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.4 | 0.4 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.4 | 1.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.4 | 3.5 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.4 | 1.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 0.9 | GO:0060686 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.4 | 1.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.4 | 1.7 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.4 | 1.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.4 | 1.7 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.4 | 1.3 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.4 | 2.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.4 | 3.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 1.7 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.4 | 0.4 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.4 | 1.3 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.4 | 0.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.4 | 5.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.4 | 1.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.4 | 0.4 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.4 | 1.3 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.4 | 1.3 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.4 | 5.5 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.4 | 1.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.4 | 2.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 1.3 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.4 | 0.8 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 2.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 1.3 | GO:0021626 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.4 | 1.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.4 | 1.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.4 | 2.5 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.4 | 3.8 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.4 | 0.4 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.4 | 1.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.4 | 2.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.4 | 1.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.4 | 0.8 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.4 | 1.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 4.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.4 | 0.8 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.4 | 2.9 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.4 | 2.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.4 | 5.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.4 | 19.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 0.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.4 | 0.8 | GO:0008354 | germ cell migration(GO:0008354) |
0.4 | 2.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.4 | 2.0 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.4 | 1.2 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.4 | 0.8 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.4 | 1.2 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.4 | 0.8 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.4 | 1.2 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.4 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.4 | 1.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.4 | 2.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 1.6 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.4 | 1.6 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.4 | 2.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.4 | 1.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.4 | 2.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.4 | 0.8 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.4 | 3.2 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.4 | 1.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.4 | 0.8 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.4 | 0.8 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.4 | 0.8 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.4 | 0.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 0.4 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.4 | 0.4 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.4 | 0.8 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.4 | 0.4 | GO:0018214 | protein carboxylation(GO:0018214) |
0.4 | 1.2 | GO:0007614 | short-term memory(GO:0007614) |
0.4 | 1.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.4 | 0.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.4 | 1.2 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.4 | 3.2 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.4 | 1.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.4 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.4 | 1.6 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.4 | 5.5 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.4 | 1.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 0.8 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.4 | 1.6 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.4 | 1.6 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.4 | 3.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.4 | 0.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.4 | 0.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.4 | 5.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 1.6 | GO:0080009 | mRNA methylation(GO:0080009) |
0.4 | 0.8 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.4 | 0.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.4 | 1.9 | GO:0046836 | glycolipid transport(GO:0046836) |
0.4 | 2.3 | GO:0009650 | UV protection(GO:0009650) |
0.4 | 12.4 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.4 | 3.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.4 | 1.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.4 | 0.8 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.4 | 0.8 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.4 | 1.9 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.4 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.4 | 1.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.4 | 3.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 0.8 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.4 | 1.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.4 | 4.9 | GO:0006414 | translational elongation(GO:0006414) |
0.4 | 1.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 0.8 | GO:0000087 | mitotic M phase(GO:0000087) |
0.4 | 1.5 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 1.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.4 | 1.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.4 | 1.9 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 11.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.4 | 5.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.4 | 0.7 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) positive regulation of protein depolymerization(GO:1901881) |
0.4 | 10.8 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.4 | 0.7 | GO:0007340 | acrosome reaction(GO:0007340) |
0.4 | 1.5 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.4 | 1.1 | GO:0009838 | abscission(GO:0009838) |
0.4 | 1.9 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.4 | 0.7 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.4 | 0.4 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
0.4 | 0.4 | GO:0016559 | peroxisome fission(GO:0016559) |
0.4 | 0.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 2.2 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.4 | 12.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.4 | 1.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.4 | 1.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.4 | 1.5 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.4 | 1.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.4 | 2.9 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.4 | 1.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.4 | 1.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.4 | 1.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.4 | 1.5 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.4 | 11.2 | GO:0006400 | tRNA modification(GO:0006400) |
0.4 | 2.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.4 | 1.1 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.4 | 0.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.4 | 9.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 1.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 1.4 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.4 | 2.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.4 | 0.7 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.4 | 1.8 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.4 | 0.4 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.4 | 0.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.4 | 1.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.4 | 0.7 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.4 | 9.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.4 | 1.8 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.4 | 1.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.4 | 2.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.4 | 4.3 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.4 | 6.0 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.4 | 2.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.4 | 2.1 | GO:0035989 | tendon development(GO:0035989) |
0.4 | 3.5 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.4 | 4.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 1.1 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 1.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.3 | 0.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.3 | 0.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.3 | 1.4 | GO:0046909 | intermembrane transport(GO:0046909) |
0.3 | 1.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.3 | 1.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 1.0 | GO:0060166 | olfactory pit development(GO:0060166) |
0.3 | 3.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.3 | 3.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.3 | 1.4 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.3 | 1.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 2.4 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.3 | 1.0 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 2.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 0.7 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.3 | 0.3 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.3 | 1.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.3 | 4.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 0.7 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.3 | 1.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 0.7 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.3 | 0.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.3 | 1.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 2.7 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.3 | 2.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 3.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 5.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 1.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 3.0 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.3 | 1.3 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 1.0 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 1.0 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.3 | 0.3 | GO:1903333 | negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.3 | 1.3 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.3 | 0.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 1.0 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.3 | 1.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 0.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.3 | 1.3 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 1.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 0.3 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.3 | 1.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 1.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.3 | 1.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.3 | 0.7 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.3 | 1.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 1.6 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.3 | 3.0 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.3 | 0.7 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 0.7 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.3 | 8.5 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.3 | 0.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.3 | 1.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.3 | 0.7 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 0.7 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.3 | 0.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 1.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.3 | 1.0 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.3 | 1.3 | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.3 | 4.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 1.0 | GO:0000237 | leptotene(GO:0000237) |
0.3 | 1.3 | GO:0006266 | DNA ligation(GO:0006266) |
0.3 | 1.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 1.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 1.0 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.3 | 0.6 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.3 | 1.9 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 1.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 1.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 0.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.3 | 0.6 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.3 | 1.0 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.3 | 2.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 0.3 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.3 | 0.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 3.8 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.3 | 4.1 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.3 | 0.9 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.3 | 1.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 0.6 | GO:0021756 | striatum development(GO:0021756) |
0.3 | 0.6 | GO:0010039 | response to iron ion(GO:0010039) |
0.3 | 0.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.3 | 3.4 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.3 | 0.9 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.3 | 0.9 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.3 | 1.6 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 4.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 0.3 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.3 | 0.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.3 | 0.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 0.9 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.3 | 2.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 0.9 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 17.2 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.3 | 1.5 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 0.9 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.3 | 0.3 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.3 | 0.3 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 1.5 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.3 | 1.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 0.3 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.3 | 1.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.3 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 0.9 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.3 | 0.9 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.3 | 0.6 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.3 | 3.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 0.3 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.3 | 0.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 0.6 | GO:0034728 | nucleosome organization(GO:0034728) |
0.3 | 1.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.3 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 0.6 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.3 | 0.6 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 2.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.3 | 12.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.3 | 0.9 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.3 | 0.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 3.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.3 | 0.3 | GO:0051088 | monocyte activation(GO:0042117) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 1.8 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 6.8 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.3 | 0.9 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 1.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.3 | 2.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 0.9 | GO:0031297 | replication fork processing(GO:0031297) |
0.3 | 1.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.3 | 0.6 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 0.9 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.3 | 0.6 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 0.3 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.3 | 0.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.3 | 2.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.3 | 1.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 0.9 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.3 | 0.3 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.3 | 1.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 1.5 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.3 | 0.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 0.9 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 0.3 | GO:0051610 | serotonin uptake(GO:0051610) |
0.3 | 0.3 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.3 | 0.9 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.3 | 0.3 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.3 | 0.3 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.3 | 2.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.3 | 1.4 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.3 | 0.6 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.3 | 1.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 2.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.3 | 7.1 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.3 | 1.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.3 | 4.8 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.3 | 2.0 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.3 | 3.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.3 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 0.3 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 0.3 | GO:1904431 | regulation of t-circle formation(GO:1904429) positive regulation of t-circle formation(GO:1904431) |
0.3 | 1.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 0.8 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.3 | 1.1 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.3 | 21.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 28.7 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.3 | 3.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 1.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.3 | 2.8 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.3 | 0.6 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.3 | 0.8 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.3 | 0.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.3 | 1.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 3.3 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.3 | 1.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.3 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 6.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.3 | 1.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.3 | 3.6 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.3 | 1.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 0.3 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.3 | 0.5 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 0.3 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.3 | 0.3 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.3 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.3 | 0.3 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.3 | 0.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.3 | 0.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 0.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 1.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 2.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 4.9 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 1.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.8 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.3 | 0.3 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.3 | 0.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.3 | 0.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.3 | 2.2 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.3 | 0.3 | GO:0006903 | vesicle targeting(GO:0006903) |
0.3 | 0.8 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 1.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.3 | 9.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 1.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 0.8 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 1.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 0.8 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 0.8 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.3 | 1.8 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.3 | 2.1 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.3 | 0.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 1.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.3 | 4.2 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.3 | 1.0 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.3 | 1.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.3 | 0.8 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.3 | 1.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 4.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 3.4 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.3 | 3.1 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.3 | 2.3 | GO:0050685 | positive regulation of mRNA processing(GO:0050685) |
0.3 | 1.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 1.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 0.5 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.3 | 3.8 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.3 | 1.8 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.3 | 0.3 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.3 | 0.5 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.3 | 0.8 | GO:0032438 | melanosome organization(GO:0032438) |
0.3 | 1.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 1.0 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.3 | 3.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.3 | 0.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.3 | 1.3 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.3 | 2.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 0.8 | GO:1902047 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.3 | 0.5 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.3 | 1.5 | GO:2000671 | motor neuron apoptotic process(GO:0097049) regulation of motor neuron apoptotic process(GO:2000671) |
0.3 | 1.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.2 | 0.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.2 | 1.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 1.0 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.2 | 0.5 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.2 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.2 | GO:0060440 | trachea formation(GO:0060440) |
0.2 | 0.2 | GO:0008050 | female courtship behavior(GO:0008050) |
0.2 | 3.0 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.7 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 1.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 4.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.2 | 1.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 0.5 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 1.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 2.2 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.2 | 1.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.5 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.7 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
0.2 | 1.0 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.2 | 0.7 | GO:0032402 | melanosome transport(GO:0032402) |
0.2 | 1.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 2.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 12.5 | GO:0007051 | spindle organization(GO:0007051) |
0.2 | 1.0 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.2 | 0.7 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.2 | 1.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.7 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.2 | 1.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.7 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.2 | 1.2 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.2 | 1.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 4.0 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.2 | 1.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.2 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.2 | 3.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.9 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 0.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.7 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 0.5 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.2 | 0.7 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 0.7 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 0.7 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.7 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 0.5 | GO:0051647 | nucleus localization(GO:0051647) |
0.2 | 1.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 4.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 1.8 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 0.7 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.2 | 0.5 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 0.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.7 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 2.5 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.2 | 0.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.2 | 1.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 0.5 | GO:0044849 | estrous cycle(GO:0044849) |
0.2 | 1.1 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 7.0 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.2 | 0.7 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 4.3 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.2 | 6.7 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.2 | 0.4 | GO:0035927 | RNA import into mitochondrion(GO:0035927) rRNA transport(GO:0051029) |
0.2 | 11.6 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.2 | 0.2 | GO:0071025 | RNA surveillance(GO:0071025) |
0.2 | 2.2 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.2 | 12.9 | GO:1903214 | regulation of protein targeting to mitochondrion(GO:1903214) |
0.2 | 3.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 2.0 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 0.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 0.7 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 0.9 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.2 | 0.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 1.1 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.2 | 2.0 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 1.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 4.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 1.5 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.2 | 0.9 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.2 | 0.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 7.1 | GO:0006497 | protein lipidation(GO:0006497) |
0.2 | 0.4 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 1.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 0.2 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 1.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 2.6 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 0.2 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.2 | 2.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 2.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.2 | 0.4 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.2 | 4.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.2 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.2 | 4.4 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 2.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 1.7 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 1.0 | GO:0032392 | DNA geometric change(GO:0032392) |
0.2 | 0.2 | GO:0046102 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.2 | 1.4 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.2 | 5.6 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 1.6 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.4 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.2 | 0.4 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.2 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 0.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 1.4 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.2 | 1.8 | GO:0009145 | purine nucleoside triphosphate biosynthetic process(GO:0009145) |
0.2 | 0.2 | GO:1900164 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.2 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 1.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 5.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 4.3 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 2.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.6 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 0.6 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 1.2 | GO:0031497 | chromatin assembly(GO:0031497) |
0.2 | 1.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.6 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.2 | 2.0 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 0.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 0.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 2.6 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 2.8 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.2 | 1.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 1.2 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.2 | 5.3 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.2 | 0.6 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.2 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 1.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 0.4 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.2 | 0.4 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 0.4 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.8 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 1.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 1.1 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.2 | 0.2 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.2 | 0.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 1.3 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.2 | 1.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 1.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 0.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.7 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 1.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 1.7 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.2 | 1.1 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.2 | 0.4 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 0.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 0.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.9 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.2 | 0.4 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.7 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.2 | 0.7 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.2 | 0.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.5 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 2.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 2.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 1.1 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 2.4 | GO:0009060 | aerobic respiration(GO:0009060) |
0.2 | 0.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 0.7 | GO:0097502 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.2 | 2.2 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.2 | 0.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 1.1 | GO:1903312 | negative regulation of mRNA metabolic process(GO:1903312) |
0.2 | 0.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 0.5 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 0.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.9 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.4 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 0.7 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.4 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.2 | 0.5 | GO:0007031 | peroxisome organization(GO:0007031) |
0.2 | 0.3 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.2 | 0.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 3.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 0.9 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 0.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.2 | 0.3 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 1.9 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.2 | 0.7 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.2 | 0.3 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 0.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.5 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.3 | GO:0061724 | lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.2 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 0.3 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 1.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.2 | 1.0 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.8 | GO:0033522 | histone monoubiquitination(GO:0010390) histone H2A ubiquitination(GO:0033522) |
0.2 | 1.2 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.2 | 0.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.2 | 1.0 | GO:0097320 | membrane tubulation(GO:0097320) |
0.2 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 1.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 1.0 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.2 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 0.6 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.2 | 0.6 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.2 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.8 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 0.3 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 0.3 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.2 | 0.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 0.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 0.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 0.3 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.2 | 0.8 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.2 | 0.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 0.6 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.2 | 0.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 1.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 0.2 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.2 | 0.2 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 0.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 0.2 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.2 | 0.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 0.2 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.2 | 0.9 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 1.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.2 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.2 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 0.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 1.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 0.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.2 | 0.8 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 0.6 | GO:0015824 | proline transport(GO:0015824) |
0.2 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 1.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0038089 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 1.2 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.1 | 0.9 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 2.8 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.4 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.4 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.1 | 1.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 5.2 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 1.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 1.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 1.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.7 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 1.3 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 4.7 | GO:0000910 | cytokinesis(GO:0000910) |
0.1 | 0.4 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.1 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 24.6 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.9 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.7 | GO:0032886 | regulation of microtubule-based process(GO:0032886) |
0.1 | 0.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.4 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.1 | 0.5 | GO:0042637 | catagen(GO:0042637) |
0.1 | 1.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.8 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.3 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 2.0 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.3 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.1 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.1 | 2.4 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 3.8 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.1 | 0.7 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.9 | GO:0071103 | DNA conformation change(GO:0071103) |
0.1 | 1.0 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.1 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.6 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 0.1 | GO:0002434 | immune complex clearance(GO:0002434) |
0.1 | 0.4 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.1 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.6 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 3.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 0.6 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.4 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.7 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 3.0 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.1 | 0.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.6 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.1 | 0.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 1.0 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 1.3 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.9 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.2 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 2.0 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.5 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 1.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.1 | GO:1903729 | regulation of plasma membrane organization(GO:1903729) |
0.1 | 0.1 | GO:0052312 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.1 | 0.2 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 1.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.2 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.1 | 0.1 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.1 | 2.0 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.2 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.6 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.7 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 2.3 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.3 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 1.8 | GO:0006396 | RNA processing(GO:0006396) |
0.1 | 1.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.1 | 0.3 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.3 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.2 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.1 | 2.2 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.6 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.1 | 0.1 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 1.0 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.1 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 0.9 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 3.0 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 1.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 1.4 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.1 | 1.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.2 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.9 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.3 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 1.2 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.1 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 2.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.3 | GO:0000279 | M phase(GO:0000279) |
0.1 | 0.1 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.1 | 0.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.2 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.1 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 0.7 | GO:0060996 | dendritic spine development(GO:0060996) |
0.1 | 0.5 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.5 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.1 | 0.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 0.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.1 | GO:0006119 | regulation of oxidative phosphorylation(GO:0002082) oxidative phosphorylation(GO:0006119) |
0.1 | 1.3 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.4 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.1 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.8 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.4 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.4 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.4 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.2 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 0.4 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.3 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.1 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 1.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.2 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.1 | 0.2 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.2 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.1 | 0.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 0.1 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.8 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 2.3 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.8 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.7 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.3 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 3.4 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.8 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.6 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.3 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.1 | 0.4 | GO:0031109 | microtubule polymerization or depolymerization(GO:0031109) |
0.1 | 3.0 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.1 | 0.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.2 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.1 | 0.5 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 1.5 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.1 | 1.4 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.2 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.2 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.1 | 6.4 | GO:0006281 | DNA repair(GO:0006281) |
0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.4 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.1 | 0.1 | GO:0001941 | postsynaptic membrane organization(GO:0001941) |
0.1 | 0.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 0.2 | GO:1903170 | negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 1.1 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.1 | 0.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.2 | GO:1902932 | positive regulation of alcohol biosynthetic process(GO:1902932) |
0.1 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.2 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.1 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.5 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 0.6 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 1.3 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.3 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.5 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.4 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.1 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.1 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.1 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.3 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.1 | 0.9 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.3 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 0.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.2 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 3.1 | GO:0044782 | cilium organization(GO:0044782) |
0.1 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.1 | GO:0032762 | mast cell cytokine production(GO:0032762) |
0.1 | 8.8 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.1 | 1.3 | GO:0016358 | dendrite development(GO:0016358) |
0.1 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.1 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.1 | 1.3 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 2.7 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 0.8 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.5 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.5 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.1 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.1 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 0.2 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.1 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.3 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.1 | 0.1 | GO:0097709 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.1 | 0.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.3 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 2.3 | GO:0007017 | microtubule-based process(GO:0007017) |
0.1 | 0.5 | GO:0015992 | proton transport(GO:0015992) |
0.1 | 0.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.2 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.1 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.3 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.2 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.0 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 1.0 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 0.2 | GO:0007127 | meiosis I(GO:0007127) |
0.0 | 0.0 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.1 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.0 | 0.3 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.0 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 7.3 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.2 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.0 | 0.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.9 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.3 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.1 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:0009201 | ribonucleoside triphosphate biosynthetic process(GO:0009201) |
0.0 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.0 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.3 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.0 | GO:0045979 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.0 | GO:0072110 | glomerular mesangial cell proliferation(GO:0072110) regulation of glomerular mesangial cell proliferation(GO:0072124) |
0.0 | 0.2 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.0 | 0.0 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.1 | GO:0045414 | regulation of interleukin-8 biosynthetic process(GO:0045414) |
0.0 | 0.4 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.1 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.0 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.5 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.0 | 0.1 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.0 | 0.1 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.3 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.2 | GO:0022406 | membrane docking(GO:0022406) |
0.0 | 0.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 1.6 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.0 | 0.0 | GO:0009156 | ribonucleoside monophosphate biosynthetic process(GO:0009156) |
0.0 | 0.0 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.6 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.0 | 0.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.0 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.2 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.2 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 3.6 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.1 | GO:0099587 | inorganic cation import into cell(GO:0098659) inorganic ion import into cell(GO:0099587) |
0.0 | 0.0 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.0 | 0.0 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.0 | GO:0060306 | regulation of membrane repolarization(GO:0060306) |
0.0 | 0.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.0 | 1.5 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.0 | GO:0002001 | renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) positive regulation of renin secretion into blood stream(GO:1900135) |
0.0 | 0.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.1 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.0 | 0.4 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.0 | 1.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.3 | 1.3 | GO:0030175 | filopodium(GO:0030175) |
1.2 | 4.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.2 | 3.5 | GO:0044393 | microspike(GO:0044393) |
1.1 | 2.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.1 | 7.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.1 | 8.5 | GO:0043083 | synaptic cleft(GO:0043083) |
1.0 | 3.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.0 | 2.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.0 | 5.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.0 | 5.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.0 | 2.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.0 | 4.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.0 | 1.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.0 | 2.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.0 | 1.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.9 | 3.7 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.9 | 1.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.9 | 11.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.9 | 2.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.8 | 0.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.8 | 0.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.8 | 1.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.8 | 6.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.8 | 3.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.8 | 1.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.8 | 5.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.8 | 2.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.8 | 2.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.8 | 5.3 | GO:0071437 | invadopodium(GO:0071437) |
0.7 | 4.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.7 | 0.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.7 | 2.2 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.7 | 0.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 3.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.7 | 5.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.7 | 2.8 | GO:0098536 | deuterosome(GO:0098536) |
0.7 | 1.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.7 | 2.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.7 | 2.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.7 | 2.8 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.7 | 2.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.7 | 2.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.7 | 4.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.7 | 2.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.7 | 1.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.7 | 18.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.6 | 15.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 3.2 | GO:0000796 | condensin complex(GO:0000796) |
0.6 | 1.9 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.6 | 0.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.6 | 1.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 4.9 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 2.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.6 | 3.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.6 | 6.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.6 | 27.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.6 | 4.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.6 | 3.6 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.6 | 0.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.6 | 12.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.6 | 2.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.6 | 0.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.6 | 3.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.6 | 1.7 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.6 | 4.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.6 | 4.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.6 | 4.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.6 | 6.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.6 | 0.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.6 | 2.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.6 | 5.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.6 | 3.4 | GO:0002177 | manchette(GO:0002177) |
0.6 | 1.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.6 | 2.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.6 | 1.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.6 | 1.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.6 | 6.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.6 | 2.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.6 | 3.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.6 | 8.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.6 | 1.7 | GO:0030891 | VCB complex(GO:0030891) |
0.5 | 1.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.5 | 3.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.5 | 4.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 3.3 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.5 | 6.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.5 | 1.6 | GO:0036396 | MIS complex(GO:0036396) |
0.5 | 4.9 | GO:0005685 | U1 snRNP(GO:0005685) |
0.5 | 13.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.5 | 0.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.5 | 5.8 | GO:0005652 | nuclear lamina(GO:0005652) |
0.5 | 6.3 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.5 | 2.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 21.0 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.5 | 21.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 5.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.5 | 3.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.5 | 8.8 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.5 | 2.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.5 | 2.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.5 | 1.5 | GO:0072534 | perineuronal net(GO:0072534) |
0.5 | 4.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.5 | 1.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 1.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 6.5 | GO:0036038 | MKS complex(GO:0036038) |
0.5 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.5 | 1.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.5 | 3.0 | GO:0070847 | core mediator complex(GO:0070847) |
0.5 | 1.0 | GO:0097452 | GAIT complex(GO:0097452) |
0.5 | 1.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 0.5 | GO:0035061 | interchromatin granule(GO:0035061) |
0.5 | 2.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.5 | 6.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 2.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.5 | 2.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.5 | 20.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.5 | 2.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.5 | 8.6 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.5 | 2.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.5 | 0.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.5 | 1.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 1.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.5 | 1.8 | GO:0097433 | dense body(GO:0097433) |
0.5 | 2.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 2.3 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 0.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 0.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 1.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 8.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.4 | 1.3 | GO:0098588 | bounding membrane of organelle(GO:0098588) |
0.4 | 2.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 4.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 10.5 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.4 | 19.7 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.4 | 5.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.4 | 1.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.4 | 0.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 0.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 1.3 | GO:0000811 | GINS complex(GO:0000811) |
0.4 | 1.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 1.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.4 | 5.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.4 | 2.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 5.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 3.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.4 | 1.7 | GO:0035363 | histone locus body(GO:0035363) |
0.4 | 3.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.4 | 0.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.4 | 8.9 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.4 | 5.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 7.6 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.4 | 0.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.4 | 1.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.4 | 2.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 0.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 5.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.4 | 2.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.4 | 4.1 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 1.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 11.0 | GO:1990391 | DNA repair complex(GO:1990391) |
0.4 | 2.8 | GO:0001939 | female pronucleus(GO:0001939) |
0.4 | 2.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 2.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 1.2 | GO:0044433 | cytoplasmic vesicle part(GO:0044433) |
0.4 | 0.8 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.4 | 1.6 | GO:0016342 | catenin complex(GO:0016342) |
0.4 | 0.4 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.4 | 26.1 | GO:0000776 | kinetochore(GO:0000776) |
0.4 | 5.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 2.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 0.8 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 1.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 1.6 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.4 | 1.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 2.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 4.6 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.4 | 1.5 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 1.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 5.3 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.4 | 12.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 54.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 2.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 1.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.4 | 0.7 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 7.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.4 | 1.9 | GO:0000805 | X chromosome(GO:0000805) |
0.4 | 2.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.4 | 3.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 0.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.4 | 1.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.4 | 1.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.4 | 0.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 1.5 | GO:0097449 | astrocyte projection(GO:0097449) |
0.4 | 5.5 | GO:0072686 | mitotic spindle(GO:0072686) |
0.4 | 1.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 3.6 | GO:0032039 | integrator complex(GO:0032039) |
0.4 | 0.7 | GO:1990752 | microtubule end(GO:1990752) |
0.4 | 1.1 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 1.4 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.4 | 3.2 | GO:0070938 | contractile ring(GO:0070938) |
0.4 | 21.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 2.5 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.4 | 1.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 3.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 1.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 1.4 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 1.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 3.5 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 3.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.3 | 3.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 3.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 10.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 0.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 4.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 3.3 | GO:0030894 | replisome(GO:0030894) |
0.3 | 0.7 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 5.6 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 1.3 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 5.3 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 4.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 2.6 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 1.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 1.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 6.4 | GO:0031902 | late endosome membrane(GO:0031902) |
0.3 | 1.3 | GO:0032021 | NELF complex(GO:0032021) |
0.3 | 13.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 0.9 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.3 | 3.8 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 2.5 | GO:0036452 | ESCRT complex(GO:0036452) |
0.3 | 0.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 1.5 | GO:0098800 | inner mitochondrial membrane protein complex(GO:0098800) |
0.3 | 0.9 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.3 | 3.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.3 | 3.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.3 | 7.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 1.8 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.3 | 2.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 2.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 2.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 4.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 1.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 2.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 1.8 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 2.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 1.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 2.7 | GO:0031011 | Ino80 complex(GO:0031011) |
0.3 | 0.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 3.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.3 | 15.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 7.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 2.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 19.9 | GO:0030496 | midbody(GO:0030496) |
0.3 | 4.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 3.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.3 | 5.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 1.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 1.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 0.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.3 | 2.6 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 0.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.3 | 0.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.3 | 0.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.3 | 8.9 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.3 | 0.6 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 0.6 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.3 | 2.0 | GO:0070187 | telosome(GO:0070187) |
0.3 | 0.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 0.3 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.3 | 2.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 0.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 1.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 1.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 1.1 | GO:1990745 | EARP complex(GO:1990745) |
0.3 | 2.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 0.8 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.3 | 0.8 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 1.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 0.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 2.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 14.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.3 | 3.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 0.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 1.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 3.6 | GO:0030684 | preribosome(GO:0030684) |
0.3 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 1.9 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 0.8 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.3 | 2.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.3 | 2.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 1.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 7.7 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 4.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 2.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.3 | 1.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 1.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 2.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 2.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 0.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 1.0 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 1.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 3.6 | GO:0043073 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
0.3 | 0.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 2.8 | GO:0001741 | XY body(GO:0001741) |
0.3 | 7.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 1.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 1.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 0.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 3.5 | GO:0043205 | fibril(GO:0043205) |
0.3 | 0.8 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 4.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 2.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 21.5 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 5.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 2.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 12.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 16.6 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 14.4 | GO:0005814 | centriole(GO:0005814) |
0.2 | 1.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 1.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 2.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 3.1 | GO:0016023 | cytoplasmic, membrane-bounded vesicle(GO:0016023) |
0.2 | 0.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.2 | 4.7 | GO:0070469 | respiratory chain(GO:0070469) |
0.2 | 5.9 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 3.3 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.2 | 0.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 1.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 6.7 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 2.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 2.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 6.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 3.4 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 1.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 0.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 0.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 38.3 | GO:0005813 | centrosome(GO:0005813) |
0.2 | 0.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 2.8 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 1.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.2 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 2.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 0.2 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 1.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 0.8 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 0.4 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 1.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 4.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 3.8 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.2 | GO:0044298 | cell body membrane(GO:0044298) |
0.2 | 1.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 0.6 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 8.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 0.8 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 1.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 0.4 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 5.0 | GO:0098794 | postsynapse(GO:0098794) |
0.2 | 0.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 2.7 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.2 | 0.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 0.2 | GO:0097346 | INO80-type complex(GO:0097346) |
0.2 | 2.6 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 7.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 5.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 1.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 37.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 1.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 8.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 0.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.9 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 0.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 4.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 0.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 67.8 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 0.9 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.2 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.2 | 0.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 5.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 9.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 2.1 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 4.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 3.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 5.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 3.4 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 118.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 0.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 1.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 5.1 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.9 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 1.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 2.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 3.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 1.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 2.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.6 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.8 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 6.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 0.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 39.8 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 12.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.9 | GO:0005819 | spindle(GO:0005819) |
0.1 | 1.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 6.0 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 2.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.1 | GO:0098576 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.1 | 1.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.5 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.1 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 3.8 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 1.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 1.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.1 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 4.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.4 | GO:0030133 | transport vesicle(GO:0030133) |
0.1 | 1.3 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.5 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 1.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 9.8 | GO:0005929 | cilium(GO:0005929) |
0.1 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 6.5 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 5.7 | GO:0045202 | synapse(GO:0045202) |
0.1 | 9.8 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.7 | GO:0031090 | organelle membrane(GO:0031090) |
0.1 | 15.3 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.1 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.1 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.1 | 1.1 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.4 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.1 | 1.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 1.5 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.7 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 1.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.1 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.4 | GO:0044297 | cell body(GO:0044297) |
0.1 | 0.1 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.1 | 0.3 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.5 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 1.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.5 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 7.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.8 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.5 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 2.3 | GO:0097458 | neuron part(GO:0097458) |
0.1 | 5.0 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 29.9 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 1.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 2.4 | GO:0097223 | sperm part(GO:0097223) |
0.0 | 18.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 1.2 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 8.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 1.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 8.9 | GO:0012505 | endomembrane system(GO:0012505) |
0.0 | 0.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 57.2 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 0.0 | GO:0008278 | nuclear cohesin complex(GO:0000798) cohesin complex(GO:0008278) |
0.0 | 0.0 | GO:0031523 | Myb complex(GO:0031523) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.2 | 6.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.0 | 9.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.0 | 17.6 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.6 | 4.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.5 | 3.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.4 | 4.3 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.4 | 5.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.4 | 1.4 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.2 | 7.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.2 | 3.7 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.1 | 3.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.1 | 1.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.1 | 4.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.0 | 3.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.0 | 3.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.0 | 3.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.0 | 4.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.0 | 4.0 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
1.0 | 1.0 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
1.0 | 1.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.0 | 2.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.0 | 3.9 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.9 | 1.9 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.9 | 3.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.9 | 3.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.9 | 1.8 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.9 | 3.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.9 | 2.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.9 | 2.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.9 | 2.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.9 | 2.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.9 | 5.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.8 | 3.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.8 | 2.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.8 | 2.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.8 | 4.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.8 | 11.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.8 | 2.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.8 | 3.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.8 | 0.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.8 | 3.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.8 | 3.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.8 | 3.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.8 | 5.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.8 | 2.3 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.8 | 1.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.7 | 4.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.7 | 17.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.7 | 2.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.7 | 2.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.7 | 3.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.7 | 0.7 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.7 | 3.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.7 | 2.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.7 | 2.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.7 | 2.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.7 | 2.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.7 | 9.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.7 | 4.1 | GO:0034046 | poly(G) binding(GO:0034046) |
0.7 | 2.8 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.7 | 8.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.7 | 0.7 | GO:0008169 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.7 | 1.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.7 | 2.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.7 | 2.7 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.7 | 4.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.7 | 2.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.6 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.6 | 1.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.6 | 2.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 4.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.6 | 1.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.6 | 5.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.6 | 2.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.6 | 1.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.6 | 0.6 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.6 | 6.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 3.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 1.8 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.6 | 4.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.6 | 1.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.6 | 1.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.6 | 4.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.6 | 2.3 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.6 | 1.7 | GO:0030519 | snoRNP binding(GO:0030519) |
0.6 | 4.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.6 | 2.8 | GO:0070728 | leucine binding(GO:0070728) |
0.6 | 4.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.6 | 2.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.6 | 1.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.6 | 2.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.6 | 12.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.6 | 2.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.6 | 1.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.5 | 2.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.5 | 1.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.5 | 3.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 10.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.5 | 3.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.5 | 1.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 3.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.5 | 1.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.5 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 2.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.5 | 1.6 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.5 | 2.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.5 | 2.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.5 | 1.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.5 | 1.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 5.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.5 | 12.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.5 | 6.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.5 | 5.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 2.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.5 | 11.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.5 | 2.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.5 | 1.5 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.5 | 4.0 | GO:0008430 | selenium binding(GO:0008430) |
0.5 | 2.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.5 | 3.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 0.5 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.5 | 0.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.5 | 2.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.5 | 1.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.5 | 11.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.5 | 3.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.5 | 1.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 2.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 2.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.5 | 2.0 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.5 | 2.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 15.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.5 | 2.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.5 | 1.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.5 | 1.4 | GO:0019003 | GDP binding(GO:0019003) |
0.5 | 0.5 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.5 | 1.0 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.5 | 2.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.5 | 5.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.5 | 9.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.5 | 1.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.5 | 1.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.5 | 4.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 2.8 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.5 | 1.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.5 | 6.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.5 | 1.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.5 | 4.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.5 | 2.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.5 | 1.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.5 | 8.7 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.5 | 2.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.5 | 7.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.5 | 9.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.4 | 4.9 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 4.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.4 | 2.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 3.6 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.4 | 8.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 0.9 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.4 | 1.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.4 | 1.3 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.4 | 1.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.4 | 3.9 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.4 | 1.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.4 | 1.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.4 | 1.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.4 | 2.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 5.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 1.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.4 | 4.8 | GO:0070403 | NAD+ binding(GO:0070403) |
0.4 | 2.6 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.4 | 2.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.4 | 2.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 3.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.4 | 1.3 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 1.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 7.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 0.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 3.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.4 | 1.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 2.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.4 | 1.7 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.4 | 8.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 1.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.4 | 1.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 1.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 1.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.4 | 1.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 1.7 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.4 | 1.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 2.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 4.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.4 | 1.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.4 | 7.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 8.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.4 | 5.8 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.4 | 1.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.4 | 2.5 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 2.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.4 | 2.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.4 | 0.4 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.4 | 0.4 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 1.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.4 | 5.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.4 | 2.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 3.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 3.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.4 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 1.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 1.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.4 | 1.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 4.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 2.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 1.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 29.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.4 | 1.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.4 | 1.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 12.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.4 | 1.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 4.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.4 | 1.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 1.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.4 | 3.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.4 | 2.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.4 | 3.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.4 | 1.9 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.4 | 0.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 1.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.4 | 1.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 1.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 1.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 0.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 1.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 1.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 2.3 | GO:0005048 | signal sequence binding(GO:0005048) |
0.4 | 3.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 1.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 2.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 8.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 4.1 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.4 | 1.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.4 | 1.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 4.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.4 | 1.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.4 | 1.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.4 | 6.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 1.8 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 2.2 | GO:0070990 | snRNP binding(GO:0070990) |
0.4 | 1.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.4 | 1.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.4 | 1.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 1.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 7.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 2.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 2.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.4 | 0.4 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.4 | 12.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 3.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.4 | 1.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 8.2 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.4 | 19.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.4 | 0.4 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.4 | 1.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 0.7 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 1.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 1.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 0.4 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.4 | 1.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.3 | 1.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 0.3 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.3 | 0.7 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.3 | 7.7 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.3 | 4.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.3 | 1.0 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.3 | 1.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 1.7 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.3 | 0.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.3 | 19.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.3 | 4.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 1.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 1.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 0.7 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 1.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.3 | 0.7 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 1.7 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 1.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 1.7 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 1.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 52.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 1.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 1.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 1.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 10.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.3 | 1.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 2.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 7.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 1.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 10.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 1.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 4.9 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.3 | 1.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 3.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 2.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 0.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 3.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 3.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.3 | 1.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 2.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 0.9 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.3 | 2.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 3.1 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.3 | 3.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 0.6 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.3 | 0.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 1.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 0.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 1.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.3 | 0.6 | GO:0018558 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.3 | 1.8 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.3 | 1.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 8.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 1.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 1.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 0.9 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.3 | 0.6 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.3 | 1.5 | GO:0015266 | protein channel activity(GO:0015266) |
0.3 | 1.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 0.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 1.8 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.3 | 6.0 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.3 | 0.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 0.6 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.3 | 2.4 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.3 | 30.3 | GO:0004386 | helicase activity(GO:0004386) |
0.3 | 0.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 0.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 2.1 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.3 | 2.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 9.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 1.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 1.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 2.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 0.6 | GO:1990188 | euchromatin binding(GO:1990188) |
0.3 | 0.8 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 0.3 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.3 | 0.8 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 1.7 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.3 | 3.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 0.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.3 | 0.3 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.3 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 0.8 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.3 | 0.8 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.3 | 7.2 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.3 | 1.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 2.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 4.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 5.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 4.6 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 3.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 3.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.3 | 5.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 4.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 1.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 0.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 1.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 4.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 1.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 2.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 3.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.3 | 8.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 0.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 0.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.3 | 1.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.3 | 0.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 0.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 0.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 0.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 1.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 0.3 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.3 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 1.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 1.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 161.6 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 0.7 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 2.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 1.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 1.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 1.0 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 1.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 6.0 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 1.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 2.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 1.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 8.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 3.5 | GO:0052634 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.2 | 1.4 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.2 | 2.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 3.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 3.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 3.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.7 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 1.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 1.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 0.9 | GO:0018499 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 1.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.7 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 2.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 1.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.4 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.2 | 31.5 | GO:0015631 | tubulin binding(GO:0015631) |
0.2 | 1.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.2 | 2.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 4.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 2.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 0.4 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.2 | 0.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 0.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 3.0 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.2 | 5.9 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.2 | 0.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 2.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 7.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 0.6 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 0.4 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 1.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 0.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 1.6 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 6.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 1.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.8 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 1.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 62.1 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.2 | 1.6 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 1.8 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 2.5 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 4.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.6 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 6.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 3.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 3.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 0.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 0.4 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 0.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.9 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 2.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 0.9 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 0.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.4 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 3.5 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.2 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.9 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 6.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 2.5 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 1.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 8.2 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.2 | 0.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 0.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 1.4 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.2 | 0.9 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.2 | 0.7 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.2 | 0.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 0.9 | GO:0009055 | electron carrier activity(GO:0009055) |
0.2 | 0.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.2 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.2 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.2 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 1.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 3.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.2 | 0.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 2.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 9.5 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 0.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 0.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 0.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 2.7 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.2 | 1.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 4.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 1.2 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 10.3 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.2 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 1.3 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 0.3 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 0.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 1.6 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.2 | 2.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 0.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 1.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 0.6 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 1.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 1.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 0.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 16.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 6.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.1 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.9 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 1.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.7 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 1.8 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 1.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 1.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 1.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 1.0 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 1.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 2.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.6 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 2.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 2.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 2.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 1.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 4.4 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 1.7 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 1.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.5 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 2.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 1.0 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 14.6 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 1.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 6.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 2.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 1.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 4.4 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 1.3 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.5 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 8.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 3.7 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 1.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.2 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 0.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 1.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.1 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 0.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.3 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 1.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 3.3 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 0.1 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.9 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 13.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 1.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 6.5 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.1 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.8 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.5 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 5.2 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.5 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 1.4 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 1.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 1.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 1.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.6 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.1 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 3.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 2.2 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.6 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.8 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 9.8 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.5 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 1.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 1.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 2.3 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.1 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.9 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 1.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.8 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 3.3 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.0 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.0 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.0 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 1.8 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.0 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.1 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.2 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 6.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 2.4 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.2 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.0 | 0.0 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.1 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.6 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 2.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.2 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.0 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.0 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.0 | 0.3 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 0.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 0.2 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.0 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.0 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 1.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.7 | 12.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.6 | 17.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 14.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.6 | 8.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.6 | 8.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 17.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.5 | 19.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.5 | 37.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.5 | 15.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 1.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 5.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 7.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.4 | 0.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 3.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 12.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 22.1 | PID E2F PATHWAY | E2F transcription factor network |
0.4 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 4.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 5.8 | PID P73PATHWAY | p73 transcription factor network |
0.4 | 8.9 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 6.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 6.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 6.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 4.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 5.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 10.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 7.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 1.6 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 0.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 1.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 2.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 4.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 1.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 4.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 1.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 6.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 2.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 14.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 1.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 2.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 2.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 2.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 1.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 2.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 5.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 1.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 1.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 7.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 5.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 3.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 3.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 3.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 1.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 4.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 1.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 2.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 2.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 2.2 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 8.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 0.9 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 0.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 3.8 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 3.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 1.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 0.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 0.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 1.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 2.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.8 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.9 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 16.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 2.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 1.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 5.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.0 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 1.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.5 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 8.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.4 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 3.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 2.9 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.2 | PID BCR 5PATHWAY | BCR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 26.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.0 | 2.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.0 | 11.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.0 | 1.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.9 | 0.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.8 | 11.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.7 | 5.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.7 | 5.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.7 | 7.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.7 | 12.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.7 | 0.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.6 | 12.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.6 | 5.9 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.6 | 10.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 0.6 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.6 | 2.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.6 | 2.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 4.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.5 | 5.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.5 | 7.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.5 | 7.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.5 | 10.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.5 | 5.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.5 | 0.5 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.5 | 5.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.5 | 12.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.5 | 1.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.5 | 5.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.5 | 7.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 11.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.5 | 38.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.5 | 6.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 5.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.5 | 1.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.5 | 9.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.5 | 4.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 3.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.5 | 0.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.5 | 4.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.5 | 5.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.5 | 0.9 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.5 | 5.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.5 | 9.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.5 | 7.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.4 | 5.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.4 | 2.7 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.4 | 17.6 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.4 | 26.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.4 | 0.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 3.9 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.4 | 4.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.4 | 9.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.4 | 1.7 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.4 | 4.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 7.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.4 | 4.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 2.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.4 | 11.0 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.4 | 5.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 3.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 3.9 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.4 | 3.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 11.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 1.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.4 | 9.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.4 | 8.0 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.4 | 5.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 9.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.4 | 7.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 1.5 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.4 | 5.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 4.1 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.4 | 12.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 32.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.4 | 2.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 4.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 3.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 3.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 2.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 8.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 2.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 3.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 5.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 8.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 2.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.3 | 5.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 0.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 5.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 10.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 2.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 2.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 5.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 0.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 1.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 3.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 1.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 12.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 2.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 11.7 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.3 | 2.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 10.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 5.8 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 4.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 3.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 2.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 3.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.3 | 10.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.3 | 10.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 0.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.3 | 6.9 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 4.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.3 | 3.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 1.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 2.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 1.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 1.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 3.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 0.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 1.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 3.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 3.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 3.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 2.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.2 | 2.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 4.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 0.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 2.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 1.1 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.2 | 1.8 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.2 | 2.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 2.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 2.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 5.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 1.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 1.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 2.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 1.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 3.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 2.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 3.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 0.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 1.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 2.2 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.2 | 1.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 13.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 0.2 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.2 | 2.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 1.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.2 | 3.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 3.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 2.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 1.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 20.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 1.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 1.0 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.2 | 0.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 1.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 1.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 0.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 3.3 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 4.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 1.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 4.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 2.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 2.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.7 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 1.6 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 0.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 1.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 2.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 1.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 2.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.6 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 1.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 0.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.6 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 3.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.0 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 4.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 1.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 2.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 1.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME TRANSCRIPTION | Genes involved in Transcription |
0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.0 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
0.0 | 0.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.3 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.0 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.0 | 0.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |